Close
Nordic 9Nordic 9

National Resilience (investor - Corporate Investor)

United States
See something wrong or missing? Let us know
Offices:San Diego
Average round investment:103M USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: United Kingdom bit.bio
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to National Resilience

Name Criteria
United States Charles River Laboratories
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Michael Diekmann
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Evotec AG
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy HAT Technology & Innovation Fund
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China GT Healthcare Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China Puhua Capital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Arch Venture Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Foresite Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States TPG
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Hitachi Ventures
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top